scorecardresearch
Monday, Feb 06, 2023
Advertisement

Hope to resolve issues faced by Indians vaccinated with Covishield travelling to EU soon: Adar Poonawalla

Covishield is the Oxford University-AstraZeneca vaccine manufactured in India by the Pune-based vaccine maker.

Serum Institute CEO Adar Poonawalla. (File)

Vaccine major Serum Institute of India chief executive officer Adar Poonawalla on Monday said he has taken up the issues faced by Indians who have taken the Covishield jab travelling to the European Union at highest levels and hoped to resolve them soon.

Covishield is the Oxford University-AstraZeneca vaccine manufactured in India by the Pune-based vaccine maker.

“I realise that a lot of Indians who have taken Covishield are facing issues with travel to the EU, I assure everyone, I have taken this up at the highest levels and hope to resolve this matter soon, both with regulators and at a diplomatic level with countries,” Poonawalla said in a tweet.

Subscriber Only Stories
ExplainSpeaking | Budget 2023-24: Economic growth, fiscal health and unem...
In Jharkhand district, block-level clubs help elderly deal with loneliness
Delhi Confidential: PM Modi, top leaders attend Nadda wedding, but QR cod...
What could be the govt’s calculations behind the slashing of the MG...

As of now European Union (EU) recognises Vaxzevria (previously COVID-19 Vaccine AstraZeneca, Oxford).

The other vaccines approved by the European Medicine Agency are Comirnaty by BioNTech-Pfizer, Moderna and Janssen (Johnson & Johnson).

First published on: 28-06-2021 at 12:39 IST
Next Story

Chennai runs out of vaccine stock, only 5,000 doses to be administered today

Latest Comment
Post Comment
Read Comments
Advertisement
Advertisement
Advertisement
Advertisement
close